How people pay for GLP-1 medicines: insurance, Medicare, cash prices and savings offers

Quick answer. People pay for GLP-1 weight-loss medicines through commercial insurance, manufacturer savings cards, cash prices from the makers, or, for some people on Medicare, a temporary $50 copay program that runs through December 31, 2026. Prices and offers change often. When you compare costs, compare the same medicine, the same dose and the same length of time, and ask what you will pay after the first month.
The main ways people pay
| Way to pay | How it works | The catch |
|---|---|---|
| Commercial insurance | Your plan decides whether it covers weight-loss use of a medicine. Lilly's savings page has different terms for people whose plan covers the medicine and people whose plan does not. | Coverage depends on your plan, and the Atlas does not know yours. Ask the plan or your prescriber. |
| Manufacturer savings card | For people with commercial insurance, a card that lowers the cost of a prescription. For Zepbound single-dose pens covered by insurance, Lilly lists as little as $25 a fill, with savings capped at $100 a month and $1,300 a year. | Not for people in any government program, including Medicare. The offer on the page ends December 31, 2026, and Lilly can change or end it without notice. |
| Manufacturer cash price | You pay the company's own price without insurance. See the table below. | Prices change, usually rise with the dose, and may not count toward an insurance deductible. |
| Medicare GLP-1 Bridge | A temporary program from July 1 to December 31, 2026, with a $50 copay for Wegovy and Zepbound for people enrolled in Medicare Part D who meet clinical criteria. | It ends in 2026. A multi-year program called BALANCE is planned to start in 2027, and plans choose whether to join. |
| Compounded product | A pharmacy makes a version for you, usually at a lower price. See what a 503A pharmacy is. | It is not FDA-approved and is not the same product. See compounded versus brand-name. |
What does Medicare pay for?
A temporary program, the Medicare GLP-1 Bridge, covers Wegovy and Zepbound for some members in 2026. It runs outside the regular Part D benefit and costs eligible people a $50 copay. Providers send prescriptions and prior authorization requests to a central processor managed by the Centers for Medicare and Medicaid Services.
To qualify, you must be in Part D and have a body mass index of 35 or more, or 27 or more plus other clinical criteria. KFF notes that the $50 copay does not count toward the Part D deductible or the $2,100 out-of-pocket cap, and that people on the low-income subsidy cannot use it for these fills. People who use a GLP-1 medicine for a covered use such as type 2 diabetes or sleep apnea stay in their Part D plan and pay its cost-sharing.
In 2027, to keep coverage, you would need to be in a Part D plan that takes part in BALANCE. Plans decide whether to join, so some people may need to switch plans in open enrollment. Check Medicare.gov and your plan for the current rules.
What are the makers' cash prices?
These are listed prices the Atlas saw on company and price-listing pages in October 2026, plus one dated news report. They are starting or listed prices. Higher doses can cost more, and the offers change.
| Medicine | Price listed | Where it was listed and what to know |
|---|---|---|
| Zepbound KwikPen, Lilly self-pay | $299 a month at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg | Lilly's Zepbound page. The page also notes that its self-pay terms bar seeking reimbursement from any third-party payer, including federal programs, and defines a month as 28 days. |
| Zepbound single-dose vials, Lilly self-pay | $299 to $449 a month, per a December 2025 report | Fierce Pharma, December 2025. A news report, and prices have moved since. |
| Wegovy pen, Novo Nordisk self-pay | $199 a month for the first two fills at 0.25 mg and 0.5 mg, for new patients only, through December 31, 2026. Then $349 a month at doses from 0.25 mg to 2.4 mg, and $399 at 7.2 mg (Wegovy HD). | Novo Nordisk's NovoCare page. Prices are per box of four pens. The page says eligibility rules apply, the company can change or cancel the program at any time, and self-pay amounts do not count toward a deductible or out-of-pocket limit. TrumpRx also lists $199 for the Wegovy pen. |
| Wegovy pill, Novo Nordisk self-pay | $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg | Novo Nordisk's NovoCare page. Prices are per bottle of 30 tablets. TrumpRx also lists $149 for the Wegovy pill, which matches the lowest dose. |
| Ozempic | $199 a month listed on TrumpRx | Ozempic is approved for type 2 diabetes. The site does not say which doses it covers. |
The Atlas could not confirm how TrumpRx fills orders or whether insurance can be used with its prices, and did not verify the listed prices.
How to compare costs
Prices are only useful side by side. These are the things to line up.

- The same medicine and the same dose. Prices often rise with the dose.
- The same length of time. Some prices count a month as 28 days and some as 30.
- What is included. Ask whether a visit, supplies, a membership or a shipping fee is extra.
- The price after the first month. An introductory price can end.
- What happens if you stop and restart, or need a higher dose.
- Whether it is the FDA-approved product or a compounded one. They are not the same product.
- How long you expect to take it. These medicines are generally taken for the long term, and in the STEP 1 extension, people who stopped semaglutide regained much of the weight they had lost.
What a monthly price adds up to over a year
This is arithmetic, not a price quote. It shows why a small monthly difference matters.
| Monthly price | Twelve months |
|---|---|
| $149 | $1,788 |
| $199 | $2,388 |
| $299 | $3,588 |
| $349 | $4,188 |
| $399 | $4,788 |
| $499 | $5,988 |
| $699 | $8,388 |
Twelve months at the monthly price shown. Real costs vary with dose changes and with what is included.
Watch out for
- A price that applies only to the first month or only to one dose.
- A quoted price with the medicine not named. Ask exactly which product and strength it covers.
- A claim that a compounded product is "FDA-approved" or "the same as" the brand-name drug.
- A savings card offered to someone on Medicare or another government program. The cards exclude them.
- Any price from a source that will not tell you which pharmacy fills the prescription.
What people report
Cost is among the most common frustrations people voice online. The themes people commonly describe are surprise at a price that jumped when the dose went up, plans that dropped coverage, and switching between options to keep the cost down.
None of this was measured, and the people who post are not a random sample. It is here to show what to expect to hear, not what you will pay.
Quick answers
- Does insurance cover Wegovy and Zepbound?
- It depends on your plan. Lilly's savings page has separate terms for people whose insurance covers Zepbound and people whose insurance does not. Ask your plan or prescriber.
- Does Medicare cover GLP-1 medicines for weight loss?
- A temporary Medicare GLP-1 Bridge runs July 1 to December 31, 2026. Eligible Part D members pay a $50 copay for Wegovy or Zepbound. A program called BALANCE is planned for 2027.
- How much do Zepbound and Wegovy cost without insurance?
- Lilly lists Zepbound KwikPen self-pay prices from $299 a month at the lowest dose to $699 at the highest. Novo Nordisk lists Wegovy pens at $349 a month after an introductory $199 for new patients, and Wegovy pills from $149 to $299 by dose. Prices change often.
- Can I use a savings card if I am on Medicare?
- No. Lilly's savings card excludes people enrolled in any government healthcare program, including Medicare.
- Why are compounded versions cheaper?
- A pharmacy makes them without going through FDA approval, so the price does not carry the same costs. They are also not FDA-approved and are not the same product. See the 503A page.
- What is the cheapest way to take a GLP-1 medicine?
- It depends on your insurance, dose and whether you take a brand-name or compounded product. Compare the same dose over the same length of time, and ask what the price will be after the first month.
Questions to ask
- Does my plan cover weight-loss use of this medicine, and what do I need for prior authorization?
- What will I pay at each dose, and what happens to the price after the first month?
- Am I eligible for a savings offer, or does my insurance or Medicare exclude me?
- If I use a cash price, does anything count toward my deductible?
- Is the product FDA-approved or compounded, and who fills the prescription?
What is still unknown
- Prices and offers change often, and the ones on this page were seen in October 2026.
- The Atlas read Novo Nordisk's and Lilly's own price pages, but did not verify the TrumpRx listings or what a pharmacy would charge you at checkout.
- Medicaid rules differ by state and were not reviewed for this page.
- What Medicare will cover in 2027 depends on which plans join BALANCE, and the Atlas does not know that yet.
Sources
- Price your Wegovy (NovoCare) Novo Nordisk, novocare.com. Self-pay prices as read in October 2026. Prices and offers can change or end at any time. Company announcement, not peer reviewed
- Zepbound coverage and savings page Eli Lilly and Company, Zepbound website. Company price and savings terms as shown on the page in October 2026; they change and are not independently verified. Company announcement, not peer reviewed
- What Medicare's temporary program covering GLP-1s for obesity means for beneficiaries KFF quick take. Policy research summary; check Medicare.gov and your plan for current rules. Trade press, secondary source
- Some Medicare beneficiaries can now get popular obesity drugs for $50 a month NPR, May 6, 2026. News report; check Medicare.gov and your plan for current rules. Trade press, secondary source
- Lilly joins Novo in GLP-1 self-pay price cuts, lowering costs of single-dose Zepbound vials Fierce Pharma, December 1, 2025. Manufacturer cash prices change often. Trade press, secondary source
- TrumpRx drug price listing trumprx.gov. Listed prices as shown on the site in October 2026. The site does not say which doses the prices cover, and the Atlas did not verify them. Price listing on a website, not independently verified
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension Wilding JPH, et al. Diabetes Obes Metab. 2022;24(8):1553-1564. PMID 35441470. Funding: Novo Nordisk. Journal article